FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. HD
4. ARGX
5. SPY

6. KLAR
7. AMLX
8. METC
9. FN
10. SNOW

August 10, 2016 12:50 PM EDT

Price: $0.30 -6.25%

Overall Analyst Rating:
SELL (= Flat)

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:

FDA, Insiders' Blog

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!